Skip to main content
Clinical Trials/DRKS00026233
DRKS00026233
Completed
未知

Investigation of language improvement in aphasia using the app neolexon Aphasie” as a home exercise supplement - AddiThA

imedix GmbH0 sites196 target enrollmentMarch 28, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
R47.0
Sponsor
imedix GmbH
Enrollment
196
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 28, 2022
End Date
October 31, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
imedix GmbH

Eligibility Criteria

Inclusion Criteria

  • Gender: w, m, d; Age: 18 years and older; Residence: Germany; Sufficient, premorbid language level in German (business fluent); Diagnosis: aphasia and/or apraxia of speech after brain injury (determined by physician/therapist); Aphasia diagnosed by BIAS\-R is present; Post\-onset time: 4 weeks or more; Has never used neolexon aphasia in selftraining; Has access to a computer/tablet and Internet; Receives (regular) standard speech and language therapy

Exclusion Criteria

  • Severe visual impairments such that images and text cannot be interpreted on a screen; severe motor restrictions that prevent the use of a tablet / computer; severe hearing impairments that impair ability to perceive auditory stimuli/instructions; severe cognitive impairments, which prevent the use of a tablet / computer; has used neolexon Aphasia in the past or is currently using neolexon Aphasia for digital home exercises

Outcomes

Primary Outcomes

Not specified

Similar Trials